The purpose of DeWorm3 is to determine the feasibility of interrupting the transmission of three types of STHs in three trial sites.
Our goals are to:
- develop epidemiological and operational definitions of STH transmission interruption.
- demonstrate the feasibility of interrupting STH transmission through mass drug administration (MDA) in settings where lymphatic filariasis (LF) programmes have progressed to post-MDA surveillance
- recommend a feasible and effective approach for scaling up STH transmission interruption programmes.